Influenza Virus Lysate Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Influenza Virus Lysate Vaccine Market Summary
Introduction
Influenza virus lysate vaccines, made from inactivated viral components, provide seasonal protection against flu strains. The market operates within the vaccine industry, driven by annual strain updates, public health initiatives, and global immunization efforts. Its reliance on predictive epidemiology and rapid production distinguishes it, though competition from recombinant and mRNA vaccines challenges its dominance. Innovations focus on efficacy, scalability, and pediatric formulations.
Market Size and Growth Forecast
The global influenza virus lysate vaccine market is estimated at USD 4 billion to USD 4.5 billion in 2025, with a CAGR of 3.5% to 5.0% from 2025 to 2030, reaching USD 5 billion to USD 5.8 billion by 2030.
Regional Analysis
North America holds 30-35%, growing at 3.0-4.0%. The U.S. leads with high vaccination rates and clinic distribution, trending toward pediatric and elderly focus, while Canada follows with public health initiatives. Europe has 25-30%, growing at 2.5-3.5%. Germany and the UK drive demand with seasonal campaigns, emphasizing hospital stockpiling. Asia Pacific accounts for 25-30%, growing at 5.0-6.5%. China and India expand with local production and child immunization trends. The Rest of the World holds 10-15%, growing at 4.0-5.0%, with Brazil prioritizing hospital-based vaccination.
Application Analysis
Hospitals account for 55-60%, growing at 3.0-4.0%, driven by inpatient care and stockpiling, with trends in emergency preparedness. Clinics represent 40-45%, growing at 4.5-5.5%, fueled by outpatient access, with trends in convenience and community outreach.
Product Type Analysis
Adult vaccines dominate with 60-65%, growing at 3.0-4.0%, valued for broad coverage, with trends in efficacy improvements. Child vaccines hold 35-40%, growing at 4.5-6.0%, focusing on safety and pediatric programs, with trends in school-based delivery.
Key Market Players
Hualan Vaccine: A Chinese innovator producing robust lysate vaccines for Asia’s health needs.
SINOVAC: A Chinese leader crafting affordable flu vaccines for widespread immunization.
Sanofi: A French giant delivering globally trusted influenza vaccines with advanced formulations.
CSL Seqirus: An Australian powerhouse specializing in seasonal flu protection solutions.
GSK: A British titan innovating in flu prevention with a focus on efficacy and reach.
Jiangsu Gdk: A Chinese specialist supplying regional markets with reliable flu vaccines.
China National Pharmaceutical Group: A Chinese conglomerate expanding domestic flu vaccine access.
Porter’s Five Forces Analysis
Threat of New Entrants: Medium. Regulatory hurdles and production complexity deter entry, but advancements in vaccine technology and high demand in emerging markets lower barriers for innovative players.
Threat of Substitutes: High. mRNA and recombinant vaccines pose significant competition, offering potentially higher efficacy, though lysate vaccines retain an edge in cost and established production infrastructure.
Bargaining Power of Buyers: Medium. Governments and healthcare providers negotiate bulk pricing and supply contracts, leveraging public health budgets, though limited alternatives temper their influence.
Bargaining Power of Suppliers: Low. Standardized raw materials and widespread availability reduce supplier leverage, with manufacturers maintaining control through scalable production networks.
Competitive Rivalry: High. A dynamic field of global players competes intensely on efficacy, production speed, and pricing, with differentiation driven by strain accuracy and distribution capabilities.
Market Opportunities and Challenges
Opportunities
Public health prioritization: Heightened global focus on flu prevention, spurred by pandemic awareness, drives vaccination rates, creating a robust demand pipeline for hospitals and clinics alike.
Emerging market growth: Expanding healthcare access in Asia Pacific and Latin America fuels child and adult immunization programs, opening new avenues for affordable, scalable lysate vaccines.
Pediatric focus: Increasing emphasis on school-based and community vaccination initiatives boosts child-specific formulations, tapping into a growing segment with long-term public health benefits.
Production scalability: Established manufacturing infrastructure allows rapid scaling to meet seasonal spikes, positioning lysate vaccines as a reliable cornerstone in global flu strategies.
Challenges
mRNA vaccine rivalry: The rise of mRNA technology, with its potential for higher efficacy and faster development, threatens lysate vaccines’ market share, necessitating innovation to remain competitive.
Strain prediction uncertainty: Inaccurate annual strain forecasts risk reduced efficacy, undermining public trust and requiring robust contingency plans to adjust production mid-season.
Cost pressures: Balancing affordability with production costs in price-sensitive regions challenges profitability, particularly as governments push for lower-cost immunization options.
Cold chain demands: Strict storage and transportation requirements strain logistics, especially in developing regions with limited infrastructure, risking supply delays and wastage.
Introduction
Influenza virus lysate vaccines, made from inactivated viral components, provide seasonal protection against flu strains. The market operates within the vaccine industry, driven by annual strain updates, public health initiatives, and global immunization efforts. Its reliance on predictive epidemiology and rapid production distinguishes it, though competition from recombinant and mRNA vaccines challenges its dominance. Innovations focus on efficacy, scalability, and pediatric formulations.
Market Size and Growth Forecast
The global influenza virus lysate vaccine market is estimated at USD 4 billion to USD 4.5 billion in 2025, with a CAGR of 3.5% to 5.0% from 2025 to 2030, reaching USD 5 billion to USD 5.8 billion by 2030.
Regional Analysis
North America holds 30-35%, growing at 3.0-4.0%. The U.S. leads with high vaccination rates and clinic distribution, trending toward pediatric and elderly focus, while Canada follows with public health initiatives. Europe has 25-30%, growing at 2.5-3.5%. Germany and the UK drive demand with seasonal campaigns, emphasizing hospital stockpiling. Asia Pacific accounts for 25-30%, growing at 5.0-6.5%. China and India expand with local production and child immunization trends. The Rest of the World holds 10-15%, growing at 4.0-5.0%, with Brazil prioritizing hospital-based vaccination.
Application Analysis
Hospitals account for 55-60%, growing at 3.0-4.0%, driven by inpatient care and stockpiling, with trends in emergency preparedness. Clinics represent 40-45%, growing at 4.5-5.5%, fueled by outpatient access, with trends in convenience and community outreach.
Product Type Analysis
Adult vaccines dominate with 60-65%, growing at 3.0-4.0%, valued for broad coverage, with trends in efficacy improvements. Child vaccines hold 35-40%, growing at 4.5-6.0%, focusing on safety and pediatric programs, with trends in school-based delivery.
Key Market Players
Hualan Vaccine: A Chinese innovator producing robust lysate vaccines for Asia’s health needs.
SINOVAC: A Chinese leader crafting affordable flu vaccines for widespread immunization.
Sanofi: A French giant delivering globally trusted influenza vaccines with advanced formulations.
CSL Seqirus: An Australian powerhouse specializing in seasonal flu protection solutions.
GSK: A British titan innovating in flu prevention with a focus on efficacy and reach.
Jiangsu Gdk: A Chinese specialist supplying regional markets with reliable flu vaccines.
China National Pharmaceutical Group: A Chinese conglomerate expanding domestic flu vaccine access.
Porter’s Five Forces Analysis
Threat of New Entrants: Medium. Regulatory hurdles and production complexity deter entry, but advancements in vaccine technology and high demand in emerging markets lower barriers for innovative players.
Threat of Substitutes: High. mRNA and recombinant vaccines pose significant competition, offering potentially higher efficacy, though lysate vaccines retain an edge in cost and established production infrastructure.
Bargaining Power of Buyers: Medium. Governments and healthcare providers negotiate bulk pricing and supply contracts, leveraging public health budgets, though limited alternatives temper their influence.
Bargaining Power of Suppliers: Low. Standardized raw materials and widespread availability reduce supplier leverage, with manufacturers maintaining control through scalable production networks.
Competitive Rivalry: High. A dynamic field of global players competes intensely on efficacy, production speed, and pricing, with differentiation driven by strain accuracy and distribution capabilities.
Market Opportunities and Challenges
Opportunities
Public health prioritization: Heightened global focus on flu prevention, spurred by pandemic awareness, drives vaccination rates, creating a robust demand pipeline for hospitals and clinics alike.
Emerging market growth: Expanding healthcare access in Asia Pacific and Latin America fuels child and adult immunization programs, opening new avenues for affordable, scalable lysate vaccines.
Pediatric focus: Increasing emphasis on school-based and community vaccination initiatives boosts child-specific formulations, tapping into a growing segment with long-term public health benefits.
Production scalability: Established manufacturing infrastructure allows rapid scaling to meet seasonal spikes, positioning lysate vaccines as a reliable cornerstone in global flu strategies.
Challenges
mRNA vaccine rivalry: The rise of mRNA technology, with its potential for higher efficacy and faster development, threatens lysate vaccines’ market share, necessitating innovation to remain competitive.
Strain prediction uncertainty: Inaccurate annual strain forecasts risk reduced efficacy, undermining public trust and requiring robust contingency plans to adjust production mid-season.
Cost pressures: Balancing affordability with production costs in price-sensitive regions challenges profitability, particularly as governments push for lower-cost immunization options.
Cold chain demands: Strict storage and transportation requirements strain logistics, especially in developing regions with limited infrastructure, risking supply delays and wastage.
CHAPTER 1 EXECUTIVE SUMMARY
CHAPTER 2 ABBREVIATION AND ACRONYMS
CHAPTER 3 PREFACE
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
CHAPTER 5 MARKET TREND ANALYSIS
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
CHAPTER 6 INDUSTRY CHAIN ANALYSIS
6.1 Upstream/Suppliers Analysis
6.2 Influenza Virus Lysate Vaccine Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
CHAPTER 7 LATEST MARKET DYNAMICS
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
CHAPTER 8 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN NORTH AMERICA (2020-2030)
8.1 Influenza Virus Lysate Vaccine Market Size
8.2 Influenza Virus Lysate Vaccine Market by End Use
8.3 Competition by Players/Suppliers
8.4 Influenza Virus Lysate Vaccine Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
CHAPTER 9 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN SOUTH AMERICA (2020-2030)
9.1 Influenza Virus Lysate Vaccine Market Size
9.2 Influenza Virus Lysate Vaccine Market by End Use
9.3 Competition by Players/Suppliers
9.4 Influenza Virus Lysate Vaccine Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
CHAPTER 10 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN ASIA & PACIFIC (2020-2030)
10.1 Influenza Virus Lysate Vaccine Market Size
10.2 Influenza Virus Lysate Vaccine Market by End Use
10.3 Competition by Players/Suppliers
10.4 Influenza Virus Lysate Vaccine Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
CHAPTER 11 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN EUROPE (2020-2030)
11.1 Influenza Virus Lysate Vaccine Market Size
11.2 Influenza Virus Lysate Vaccine Market by End Use
11.3 Competition by Players/Suppliers
11.4 Influenza Virus Lysate Vaccine Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
CHAPTER 12 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN MEA (2020-2030)
12.1 Influenza Virus Lysate Vaccine Market Size
12.2 Influenza Virus Lysate Vaccine Market by End Use
12.3 Competition by Players/Suppliers
12.4 Influenza Virus Lysate Vaccine Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
CHAPTER 13 SUMMARY FOR GLOBAL INFLUENZA VIRUS LYSATE VACCINE MARKET (2020-2025)
13.1 Influenza Virus Lysate Vaccine Market Size
13.2 Influenza Virus Lysate Vaccine Market by End Use
13.3 Competition by Players/Suppliers
13.4 Influenza Virus Lysate Vaccine Market Size by Type
CHAPTER 14 GLOBAL INFLUENZA VIRUS LYSATE VACCINE MARKET FORECAST (2025-2030)
14.1 Influenza Virus Lysate Vaccine Market Size Forecast
14.2 Influenza Virus Lysate Vaccine Application Forecast
14.3 Competition by Players/Suppliers
14.4 Influenza Virus Lysate Vaccine Type Forecast
CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS
15.1 Hualan Vaccine
15.1.1 Company Profile
15.1.2 Main Business and Influenza Virus Lysate Vaccine Information
15.1.3 SWOT Analysis of Hualan Vaccine
15.1.4 Hualan Vaccine Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.2 SINOVAC
15.2.1 Company Profile
15.2.2 Main Business and Influenza Virus Lysate Vaccine Information
15.2.3 SWOT Analysis of SINOVAC
15.2.4 SINOVAC Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sanofi
15.3.1 Company Profile
15.3.2 Main Business and Influenza Virus Lysate Vaccine Information
15.3.3 SWOT Analysis of Sanofi
15.3.4 Sanofi Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.4 CSL Seqirus
15.4.1 Company Profile
15.4.2 Main Business and Influenza Virus Lysate Vaccine Information
15.4.3 SWOT Analysis of CSL Seqirus
15.4.4 CSL Seqirus Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Influenza Virus Lysate Vaccine Report
Table Data Sources of Influenza Virus Lysate Vaccine Report
Table Major Assumptions of Influenza Virus Lysate Vaccine Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Influenza Virus Lysate Vaccine Picture
Table Influenza Virus Lysate Vaccine Classification
Table Influenza Virus Lysate Vaccine Applications
Table Drivers of Influenza Virus Lysate Vaccine Market
Table Restraints of Influenza Virus Lysate Vaccine Market
Table Opportunities of Influenza Virus Lysate Vaccine Market
Table Threats of Influenza Virus Lysate Vaccine Market
Table Covid-19 Impact For Influenza Virus Lysate Vaccine Market
Table Raw Materials Suppliers
Table Different Production Methods of Influenza Virus Lysate Vaccine
Table Cost Structure Analysis of Influenza Virus Lysate Vaccine
Table Key End Users
Table Latest News of Influenza Virus Lysate Vaccine Market
Table Merger and Acquisition
Table Planned/Future Project of Influenza Virus Lysate Vaccine Market
Table Policy of Influenza Virus Lysate Vaccine Market
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 North America Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 North America Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 North America Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 United States Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Canada Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Mexico Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 South America Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 South America Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 South America Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Brazil Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Argentina Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Chile Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Peru Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Asia & Pacific Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 Asia & Pacific Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 China Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 India Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Japan Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South Korea Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Southeast Asia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Australia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Europe Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 Europe Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Germany Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 France Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 United Kingdom Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Italy Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Spain Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Belgium Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Netherlands Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Austria Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Poland Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Russia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 MEA Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 MEA Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Egypt Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Israel Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South Africa Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Gulf Cooperation Council Countries Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Turkey Influenza Virus Lysate Vaccine Market Size
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Region
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size Share by Region
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Share by Application
Table 2020-2025 Global Influenza Virus Lysate Vaccine Key Vendors Revenue
Figure 2020-2025 Global Influenza Virus Lysate Vaccine Market Size and Growth Rate
Table 2020-2025 Global Influenza Virus Lysate Vaccine Key Vendors Market Share
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Share by Type
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Region
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size Share by Region
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Application
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Share by Application
Table 2025-2030 Global Influenza Virus Lysate Vaccine Key Vendors Revenue
Figure 2025-2030 Global Influenza Virus Lysate Vaccine Market Size and Growth Rate
Table 2025-2030 Global Influenza Virus Lysate Vaccine Key Vendors Market Share
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Type
Table 2025-2030 Influenza Virus Lysate Vaccine Global Market Share by Type
CHAPTER 2 ABBREVIATION AND ACRONYMS
CHAPTER 3 PREFACE
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
CHAPTER 5 MARKET TREND ANALYSIS
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
CHAPTER 6 INDUSTRY CHAIN ANALYSIS
6.1 Upstream/Suppliers Analysis
6.2 Influenza Virus Lysate Vaccine Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
CHAPTER 7 LATEST MARKET DYNAMICS
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
CHAPTER 8 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN NORTH AMERICA (2020-2030)
8.1 Influenza Virus Lysate Vaccine Market Size
8.2 Influenza Virus Lysate Vaccine Market by End Use
8.3 Competition by Players/Suppliers
8.4 Influenza Virus Lysate Vaccine Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
CHAPTER 9 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN SOUTH AMERICA (2020-2030)
9.1 Influenza Virus Lysate Vaccine Market Size
9.2 Influenza Virus Lysate Vaccine Market by End Use
9.3 Competition by Players/Suppliers
9.4 Influenza Virus Lysate Vaccine Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
CHAPTER 10 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN ASIA & PACIFIC (2020-2030)
10.1 Influenza Virus Lysate Vaccine Market Size
10.2 Influenza Virus Lysate Vaccine Market by End Use
10.3 Competition by Players/Suppliers
10.4 Influenza Virus Lysate Vaccine Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
CHAPTER 11 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN EUROPE (2020-2030)
11.1 Influenza Virus Lysate Vaccine Market Size
11.2 Influenza Virus Lysate Vaccine Market by End Use
11.3 Competition by Players/Suppliers
11.4 Influenza Virus Lysate Vaccine Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
CHAPTER 12 HISTORICAL AND FORECAST INFLUENZA VIRUS LYSATE VACCINE MARKET IN MEA (2020-2030)
12.1 Influenza Virus Lysate Vaccine Market Size
12.2 Influenza Virus Lysate Vaccine Market by End Use
12.3 Competition by Players/Suppliers
12.4 Influenza Virus Lysate Vaccine Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
CHAPTER 13 SUMMARY FOR GLOBAL INFLUENZA VIRUS LYSATE VACCINE MARKET (2020-2025)
13.1 Influenza Virus Lysate Vaccine Market Size
13.2 Influenza Virus Lysate Vaccine Market by End Use
13.3 Competition by Players/Suppliers
13.4 Influenza Virus Lysate Vaccine Market Size by Type
CHAPTER 14 GLOBAL INFLUENZA VIRUS LYSATE VACCINE MARKET FORECAST (2025-2030)
14.1 Influenza Virus Lysate Vaccine Market Size Forecast
14.2 Influenza Virus Lysate Vaccine Application Forecast
14.3 Competition by Players/Suppliers
14.4 Influenza Virus Lysate Vaccine Type Forecast
CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS
15.1 Hualan Vaccine
15.1.1 Company Profile
15.1.2 Main Business and Influenza Virus Lysate Vaccine Information
15.1.3 SWOT Analysis of Hualan Vaccine
15.1.4 Hualan Vaccine Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.2 SINOVAC
15.2.1 Company Profile
15.2.2 Main Business and Influenza Virus Lysate Vaccine Information
15.2.3 SWOT Analysis of SINOVAC
15.2.4 SINOVAC Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sanofi
15.3.1 Company Profile
15.3.2 Main Business and Influenza Virus Lysate Vaccine Information
15.3.3 SWOT Analysis of Sanofi
15.3.4 Sanofi Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
15.4 CSL Seqirus
15.4.1 Company Profile
15.4.2 Main Business and Influenza Virus Lysate Vaccine Information
15.4.3 SWOT Analysis of CSL Seqirus
15.4.4 CSL Seqirus Influenza Virus Lysate Vaccine Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Influenza Virus Lysate Vaccine Report
Table Data Sources of Influenza Virus Lysate Vaccine Report
Table Major Assumptions of Influenza Virus Lysate Vaccine Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Influenza Virus Lysate Vaccine Picture
Table Influenza Virus Lysate Vaccine Classification
Table Influenza Virus Lysate Vaccine Applications
Table Drivers of Influenza Virus Lysate Vaccine Market
Table Restraints of Influenza Virus Lysate Vaccine Market
Table Opportunities of Influenza Virus Lysate Vaccine Market
Table Threats of Influenza Virus Lysate Vaccine Market
Table Covid-19 Impact For Influenza Virus Lysate Vaccine Market
Table Raw Materials Suppliers
Table Different Production Methods of Influenza Virus Lysate Vaccine
Table Cost Structure Analysis of Influenza Virus Lysate Vaccine
Table Key End Users
Table Latest News of Influenza Virus Lysate Vaccine Market
Table Merger and Acquisition
Table Planned/Future Project of Influenza Virus Lysate Vaccine Market
Table Policy of Influenza Virus Lysate Vaccine Market
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 North America Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 North America Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 North America Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 North America Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 United States Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Canada Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Mexico Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 South America Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 South America Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 South America Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 South America Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Brazil Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Argentina Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Chile Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Peru Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Asia & Pacific Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 Asia & Pacific Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 Asia & Pacific Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 China Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 India Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Japan Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South Korea Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Southeast Asia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Australia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Europe Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 Europe Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 Europe Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Germany Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 France Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 United Kingdom Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Italy Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Spain Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Belgium Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Netherlands Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Austria Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Poland Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Russia Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size
Figure 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size and CAGR
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 MEA Influenza Virus Lysate Vaccine Key Players Revenue
Table 2020-2025 MEA Influenza Virus Lysate Vaccine Key Players Market Share
Table 2020-2030 MEA Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2030 Egypt Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Israel Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 South Africa Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Gulf Cooperation Council Countries Influenza Virus Lysate Vaccine Market Size
Table 2020-2030 Turkey Influenza Virus Lysate Vaccine Market Size
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Region
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size Share by Region
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Application
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Share by Application
Table 2020-2025 Global Influenza Virus Lysate Vaccine Key Vendors Revenue
Figure 2020-2025 Global Influenza Virus Lysate Vaccine Market Size and Growth Rate
Table 2020-2025 Global Influenza Virus Lysate Vaccine Key Vendors Market Share
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Size by Type
Table 2020-2025 Global Influenza Virus Lysate Vaccine Market Share by Type
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Region
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size Share by Region
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Application
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Share by Application
Table 2025-2030 Global Influenza Virus Lysate Vaccine Key Vendors Revenue
Figure 2025-2030 Global Influenza Virus Lysate Vaccine Market Size and Growth Rate
Table 2025-2030 Global Influenza Virus Lysate Vaccine Key Vendors Market Share
Table 2025-2030 Global Influenza Virus Lysate Vaccine Market Size by Type
Table 2025-2030 Influenza Virus Lysate Vaccine Global Market Share by Type
